P
Piramal Pharma
PPLPHARMA Share Price
HealthcarePPLPHARMA Fundamentals
Company Valuation
Market Cap (₹ Cr.)
23,907
PE Ratio
-75.00
PB Ratio
2.99
Dividend Yield
0.08%
ROE
1.12%
ROCE
7.02%
Book Value (₹)
61.42
Face Value (₹)
10.00
Analyse PPLPHARMA with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 34.95% | 34.86% | 34.86% | 34.86% | 34.86% |
| Domestic Institutional Investors (DII) | 14.78% | 14.26% | 14.89% | 15.69% | 15.61% |
| Foreign Institutional Investors (FII) | 31.49% | 30.86% | 30.27% | 29.66% | 30.18% |
| Public Investors | 13.11% | 14.07% | 14.12% | 14.11% | 13.74% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
PPLPHARMA Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Smallcap
BSE Scrip Code
143635
NSE Scrip Name
PPLPHARMA
ISIN
INE0DK501011



